Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,336Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12Boehringer Ingelheim Pty Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Rare Disease Summit
Not Confirmed
arrow
arrow
Rare Disease Summit
Not Confirmed

Linagliptin + metformin

Brand Name : Trajentamet

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Linagliptin + metformin

Brand Name : Trajentamet

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Linagliptin + metformin

Brand Name : Trajentamet

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Empagliflozin + linagliptin

Brand Name : Glyxambi

Dosage Form : Tablet

Dosage Strength : 25MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Empagliflozin + linagliptin

Brand Name : Glyxambi

Dosage Form :

Dosage Strength :

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Linagliptin + metformin

Brand Name : Trajentamet

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

RNA Leaders
Not Confirmed
arrow
arrow
RNA Leaders
Not Confirmed

Empagliflozin + linagliptin

Brand Name : Glyxambi

Dosage Form : Tablet

Dosage Strength : 25MG

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

Rare Disease Summit
Not Confirmed
arrow
arrow
Rare Disease Summit
Not Confirmed

Linagliptin

Brand Name : Trajenta

Dosage Form : tablet

Dosage Strength : 5 mg

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

Rare Disease Summit
Not Confirmed
arrow
arrow
Rare Disease Summit
Not Confirmed

Empagliflozin + linagliptin

Brand Name : Glyxambi

Dosage Form :

Dosage Strength :

Packaging : 30

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

Rare Disease Summit
Not Confirmed
arrow
arrow
Rare Disease Summit
Not Confirmed

Linagliptin + metformin

Brand Name : Trajentamet

Dosage Form : Tablet

Dosage Strength : 2.5MG

Packaging : 60

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank